Why the study?
Given the carotid body's emergence as a therapeutic target for cardio-respiratory-metabolic diseases and the expansive functions of the chemoreflex, mechanisms explaining differential control of individual responses were sought.
Understanding the differential control of individual chemoreflex responses could allow for targeted therapeutic modulation in cardio-respiratory-metabolic diseases.
The carotid body has emerged as a therapeutic target for cardio-respiratory-metabolic diseases. With the expansive functions of the chemoreflex, we sought mechanisms to explain differential control of individual responses. We purport a remarkable correlation between phenotype of a chemosensory unit (glomus cell-sensory afferent) with a distinct component of the reflex response. This logic could permit differential modulation of distinct chemoreflex responses, a strategy ideal for therapeutic exploitation.
No takes yet. Share an insight, caveat, or question.
Żera et al. (2019) conducted a review in Cardio-respiratory-metabolic diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: